Mood Disorders News

Mental health declined substantially across the entire COVID-19 pandemic period, with women, those with higher degrees and younger adults affected most, according to a study from the U.K.

Use of a virtual reality device shows promise in alleviating stress and anxiety in health care providers during high-stress intervals such as a pandemic, according to a study published in the Journal of Primary Care & Community Health.

The FDA has granted approval to Intra-Cellular Therapies Inc. for 10.5 mg and 21 mg dosages of lumateperone to treat schizophrenia and bipolar depression, according to a company release.

Significant mental health benefits arise for adults who engage in regular physical activity, even at levels below public health recommendations, according to a systematic review published in JAMA Psychiatry.

Diagnoses of psychiatric disorders were associated with increased incidence of COVID-19 breakthrough infection in VA patients, with the strongest associations found in older patients, according to a study published in JAMA Network Open.

A new effort from the American Psychiatric Association plans to address mental health professionals’ experience with and attitudes toward treating pregnant women with mental and substance use disorders, and to identify gaps in training.

The American Psychiatric Association on Wednesday announced the launch of PsychPRO 2.0, a mental health registry that offers psychiatrists enhanced options to engage with patients, track outcomes and streamline data for quality reporting.

OxfordVR has announced a successful new virtual reality therapy for patients with mental illnesses such as schizophrenia and mood disorders with psychotic symptoms.

People with schizophrenia were less likely to have received a COVID-19 booster, while gaps in acquisition were greatest for the first vaccination, according to a retrospective cohort study published in JAMA Psychiatry.

Children with strabismus may be at an increased risk for mental illness, according to a large cross-sectional study. A moderate association was found between strabismus and anxiety disorder, schizophrenia, depression and bipolar disorder.